Stable amorphous form of daclatasvir

A process for the preparation daclatasvir or a pharmaceutically acceptable salt thereof, wherein the process includes the synthetic step of reacting a compound of Formula (I) with a compound of Formula (II): Wherein LG is a leaving group and Z is a protecting group. The protecting group Z may be sel...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Roman Gerber Aeschbacher, Armine Aramayisyan, Sven Haferkamp, Miriam Oberholzer, Arsen Sahakyan, Viktorya Rstakyan, David Hambardzumyan
Format:	Patent
Sprache:	eng
Schlagworte:	APPARATUS THEREFOR CHEMISTRY CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION ORPROCESSING OF GOODS GENERAL METHODS OF ORGANIC CHEMISTRY GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!